• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

pRb/RBL2-E2F1/4-GCN5轴通过旁分泌机制调节癌症干细胞的形成以及G0期的进入/退出。

The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms.

作者信息

Chang Chao-Hui, Liu Feng, Militi Stefania, Hester Svenja, Nibhani Reshma, Deng Siwei, Dunford James, Rendek Aniko, Soonawalla Zahir, Fischer Roman, Oppermann Udo, Pauklin Siim

机构信息

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Old Road, Oxford, OX3 7LD, UK.

Target Discovery Institute, Nuffield Department of Medicine, Old Road, University of Oxford, Oxford, OX3 7FZ, UK.

出版信息

Nat Commun. 2024 Apr 27;15(1):3580. doi: 10.1038/s41467-024-47680-z.

DOI:10.1038/s41467-024-47680-z
PMID:38678032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11055877/
Abstract

The lethality, chemoresistance and metastatic characteristics of cancers are associated with phenotypically plastic cancer stem cells (CSCs). How the non-cell autonomous signalling pathways and cell-autonomous transcriptional machinery orchestrate the stem cell-like characteristics of CSCs is still poorly understood. Here we use a quantitative proteomic approach for identifying secreted proteins of CSCs in pancreatic cancer. We uncover that the cell-autonomous E2F1/4-pRb/RBL2 axis balances non-cell-autonomous signalling in healthy ductal cells but becomes deregulated upon KRAS mutation. E2F1 and E2F4 induce whereas pRb/RBL2 reduce WNT ligand expression (e.g. WNT7A, WNT7B, WNT10A, WNT4) thereby regulating self-renewal, chemoresistance and invasiveness of CSCs in both PDAC and breast cancer, and fibroblast proliferation. Screening for epigenetic enzymes identifies GCN5 as a regulator of CSCs that deposits H3K9ac onto WNT promoters and enhancers. Collectively, paracrine signalling pathways are controlled by the E2F-GCN5-RB axis in diverse cancers and this could be a therapeutic target for eliminating CSCs.

摘要

癌症的致死性、化疗耐药性和转移特性与表型可塑性癌症干细胞(CSCs)相关。非细胞自主信号通路和细胞自主转录机制如何协调CSCs的干细胞样特性仍知之甚少。在此,我们使用定量蛋白质组学方法来鉴定胰腺癌中CSCs分泌的蛋白质。我们发现,细胞自主的E2F1/4-pRb/RBL2轴在健康导管细胞中平衡非细胞自主信号,但在KRAS突变后失调。E2F1和E2F4诱导而pRb/RBL2降低WNT配体表达(如WNT7A、WNT7B、WNT10A、WNT4),从而调节胰腺癌和乳腺癌中CSCs的自我更新、化疗耐药性和侵袭性,以及成纤维细胞增殖。对表观遗传酶的筛选确定GCN5是CSCs的调节因子,它将H3K9ac沉积到WNT启动子和增强子上。总的来说,旁分泌信号通路在多种癌症中受E2F-GCN5-RB轴控制,这可能是消除CSCs的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/1232330a6977/41467_2024_47680_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/1c431a5bf14a/41467_2024_47680_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/1ed2d6cb84ab/41467_2024_47680_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/64ffedd09273/41467_2024_47680_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/73c30c9a444d/41467_2024_47680_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/34930a81ee10/41467_2024_47680_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/84d57b5ae87f/41467_2024_47680_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/8fdd3ad683aa/41467_2024_47680_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/1232330a6977/41467_2024_47680_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/1c431a5bf14a/41467_2024_47680_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/1ed2d6cb84ab/41467_2024_47680_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/64ffedd09273/41467_2024_47680_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/73c30c9a444d/41467_2024_47680_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/34930a81ee10/41467_2024_47680_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/84d57b5ae87f/41467_2024_47680_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/8fdd3ad683aa/41467_2024_47680_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1069/11055877/1232330a6977/41467_2024_47680_Fig8_HTML.jpg

相似文献

1
The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms.pRb/RBL2-E2F1/4-GCN5轴通过旁分泌机制调节癌症干细胞的形成以及G0期的进入/退出。
Nat Commun. 2024 Apr 27;15(1):3580. doi: 10.1038/s41467-024-47680-z.
2
Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis.胰腺肿瘤微环境因子通过 SPP1-CD44 轴促进癌症干性。
Gastroenterology. 2021 Dec;161(6):1998-2013.e7. doi: 10.1053/j.gastro.2021.08.023. Epub 2021 Aug 19.
3
E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.E2F-组蛋白去乙酰化酶复合物对乳腺癌中的肿瘤抑制基因ARHI起负调控作用。
Oncogene. 2006 Jan 12;25(2):230-9. doi: 10.1038/sj.onc.1209025.
4
The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells.miR-17-92簇可抵消胰腺癌干细胞特定亚群中的静止状态和化疗耐药性。
Gut. 2015 Dec;64(12):1936-48. doi: 10.1136/gutjnl-2014-308470. Epub 2015 Apr 17.
5
MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes.miR-17-5p 通过破坏 RBL2/E2F4 抑制复合物改变细胞周期谱来增强胰腺癌增殖。
Cancer Lett. 2018 Jan 1;412:59-68. doi: 10.1016/j.canlet.2017.09.044. Epub 2017 Oct 4.
6
Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.尼古丁通过 Gata6 依赖性去分化胰腺腺泡细胞促进 KRAS 诱导的胰腺癌的发生和进展。
Gastroenterology. 2014 Nov;147(5):1119-33.e4. doi: 10.1053/j.gastro.2014.08.002. Epub 2014 Aug 12.
7
E2F transcription factors promote tumorigenicity in pancreatic ductal adenocarcinoma.E2F 转录因子促进胰腺导管腺癌的肿瘤发生。
Cancer Med. 2024 May;13(9):e7187. doi: 10.1002/cam4.7187.
8
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.致癌基因消融抗性胰腺癌细胞依赖于线粒体功能。
Nature. 2014 Oct 30;514(7524):628-32. doi: 10.1038/nature13611. Epub 2014 Aug 10.
9
BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma.BRD9 通过调控 SMAD2/3 信号通路维持胰腺导管腺癌干细胞干性和肿瘤发生。
Gastroenterology. 2024 Jan;166(1):139-154. doi: 10.1053/j.gastro.2023.09.021. Epub 2023 Sep 21.
10
The Retinoblastoma Tumor Suppressor Protein (pRb)/E2 Promoter Binding Factor 1 (E2F1) Pathway as a Novel Mediator of TGFβ-induced Autophagy.视网膜母细胞瘤肿瘤抑制蛋白(pRb)/E2启动子结合因子1(E2F1)通路作为TGFβ诱导自噬的新型介质
J Biol Chem. 2016 Jan 29;291(5):2043-54. doi: 10.1074/jbc.M115.678557. Epub 2015 Nov 23.

引用本文的文献

1
E2F1-autophagy-ALDH1A1 axis enhances self-renewal and drug resistance of lung cancer stem-like cells in a p53-dependent manner.E2F1-自噬-ALDH1A1轴以p53依赖的方式增强肺癌干细胞样细胞的自我更新能力和耐药性。
J Exp Clin Cancer Res. 2025 Aug 30;44(1):261. doi: 10.1186/s13046-025-03506-4.
2
Pancreatic Cancer Immunotherapy: A Team-Based Approach.胰腺癌免疫疗法:一种基于团队的方法。
Cancer Treat Res. 2025;129:221-266. doi: 10.1007/978-3-031-97242-3_11.
3
Isorhamnetin: Reviewing Recent Developments in Anticancer Mechanisms and Nanoformulation-Driven Delivery.

本文引用的文献

1
BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma.BRD9 通过调控 SMAD2/3 信号通路维持胰腺导管腺癌干细胞干性和肿瘤发生。
Gastroenterology. 2024 Jan;166(1):139-154. doi: 10.1053/j.gastro.2023.09.021. Epub 2023 Sep 21.
2
KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristics.KMT2A 与 PHF5A-PHF14-HMG20A-RAI1 亚复合物在胰腺癌干细胞中相互作用,并通过表观遗传调控其特征。
Nat Commun. 2023 Sep 14;14(1):5685. doi: 10.1038/s41467-023-41297-4.
3
Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment.
异鼠李素:抗癌机制及纳米制剂驱动递送的最新进展综述
Int J Mol Sci. 2025 Jul 30;26(15):7381. doi: 10.3390/ijms26157381.
4
Epigenetic regulation of cancer stemness.癌症干性的表观遗传调控。
Signal Transduct Target Ther. 2025 Aug 1;10(1):243. doi: 10.1038/s41392-025-02340-6.
5
DSG2 promotes pancreatic cancer stem cell maintenance via support of tumour and macrophage cellular cross-talk.桥粒芯糖蛋白2通过支持肿瘤与巨噬细胞的细胞间相互作用促进胰腺癌干细胞的维持。
Cell Death Dis. 2025 Jul 4;16(1):492. doi: 10.1038/s41419-025-07833-4.
6
Effects of Wnt10a on dentinogenesis of dental pulp cells in a 3-dimensional culture system using atelocollagen gel.在使用去端胶原蛋白凝胶的三维培养系统中,Wnt10a对牙髓细胞牙本质形成的影响。
Odontology. 2025 Jun 25. doi: 10.1007/s10266-025-01137-x.
7
Malignant epithelial cell marker-driven risk signature enables precise stratification in esophageal cancer.恶性上皮细胞标志物驱动的风险特征可实现食管癌的精准分层。
Front Immunol. 2025 May 27;16:1610991. doi: 10.3389/fimmu.2025.1610991. eCollection 2025.
8
HPV16 E7 Enhances Cell Stemness via RTKN2-Mediated Activation of the NF-κB Pathway in Cervical Cancer.人乳头瘤病毒16型E7蛋白通过RTKN2介导的核因子κB信号通路激活增强宫颈癌的细胞干性
Biochem Genet. 2025 Jun 10. doi: 10.1007/s10528-025-11144-w.
9
Prunin: An Emerging Anticancer Flavonoid.李属苷:一种新兴的抗癌类黄酮。
Int J Mol Sci. 2025 Mar 16;26(6):2678. doi: 10.3390/ijms26062678.
10
Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies.增强子重编程:在癌症中的关键作用及有前景的治疗策略
Cell Death Discov. 2025 Mar 3;11(1):84. doi: 10.1038/s41420-025-02366-3.
单细胞 RNA 测序揭示了化疗对人胰腺导管腺癌及其肿瘤微环境的影响。
Nat Commun. 2023 Feb 13;14(1):797. doi: 10.1038/s41467-023-36296-4.
4
Inside the stemness engine: Mechanistic links between deregulated transcription factors and stemness in cancer.在干性引擎的内部:失调转录因子与癌症干性之间的机制联系。
Semin Cancer Biol. 2022 Dec;87:48-83. doi: 10.1016/j.semcancer.2022.11.001. Epub 2022 Nov 5.
5
The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC.细胞外基质:胰腺癌中癌症干细胞迁移、转移形成及耐药性的关键协同因子
Cancers (Basel). 2022 Aug 18;14(16):3998. doi: 10.3390/cancers14163998.
6
Single-cell roadmap of human gonadal development.人类性腺发育的单细胞图谱。
Nature. 2022 Jul;607(7919):540-547. doi: 10.1038/s41586-022-04918-4. Epub 2022 Jul 6.
7
Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance.耐药性乳腺癌干细胞样细胞:克服耐药性的机制及新型治疗策略综述
Front Oncol. 2022 Mar 21;12:856974. doi: 10.3389/fonc.2022.856974. eCollection 2022.
8
The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences.PRIDE 数据库资源在 2022 年:一个基于质谱的蛋白质组学证据的中心。
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552. doi: 10.1093/nar/gkab1038.
9
Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches.胰腺癌微环境与细胞组成:当前认识与治疗方法
Cancers (Basel). 2021 Oct 8;13(19):5028. doi: 10.3390/cancers13195028.
10
Mechanisms of Cancer Cell Death: Therapeutic Implications for Pancreatic Ductal Adenocarcinoma.癌细胞死亡机制:对胰腺导管腺癌的治疗意义
Cancers (Basel). 2021 Sep 28;13(19):4834. doi: 10.3390/cancers13194834.